Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital
NCT ID: NCT07335640
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-06-11
2026-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
NCT04967066
Respiratory Physiology in Children With Febrile Seizures.
NCT01906619
Assessment of Pre Hospital Rescue Intervention for Seizure in Pediatric Patients
NCT06723431
Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
NCT03490487
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First visit to the SAUP for a simple febrile seizure
* Meeting the clinical criteria for FCS:
* Generalized seizure lasting less than 15 minutes
* No post-critical deficit
* No recurrence of seizures within 24 hours
* No personal history of neurological disorders
* Occurrence between January 1, 2022, and May 1, 2025
* First or second episode of FSFS at the time of consultation
* Presence of one of the two parents during the consultation at the SAUP
Exclusion Criteria
* Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department.
* Child who does not meet the criteria for simple febrile seizures:
* aged less than 9 months or more than 5 years at the time of diagnosis.
* Non-febrile seizure
* Focal seizure
* Seizure duration \>15 min
* Presence of post-critical deficit
* Multiple seizures within 24 hours
* Personal neurological history.
* Seizure occurring outside the period of interest (January 1, 2022 to May 1, 2025)
* Absence of parents during the SAUP consultation
9 Months
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9695
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.